Skip to content

Why Subscribe
About Us
Accreditation
Library
Live Events
Sign Up / Login

Why Subscribe
About Us
Accreditation
Library
Live Events
Sign Up / Login

Library

By pinki shah / May 14, 2022

Speciality

Author / Speaker

Title of Presentation

Type of Media

Event

2024 Event

Clear

Displaying 676 - 700 of 2,573

«
1
…
26
27
28
29
30
…
103
»

GU Cancer and State of the Art: Castration Resistant Prostate Cancer

GU Cancer and State of the Art: Castration Resistant Prostate Cancer

By: Mamta Parikh, MD, MS

Updates in Genitourinary Cancers

Updates in Genitourinary Cancers

By: Mamta Parikh, MD, MS

Renal Cell Cancer: Emerging Standards of Care and Future Directions

Renal Cell Cancer: Emerging Standards of Care and Future Directions

By: Mamta Parikh, MD, MS

Castration Resistant Prostate Cancer: What is the Optimal Strategy?

Castration Resistant Prostate Cancer: What is the Optimal Strategy?

By: Mamta Parikh, MD, MS

State of the Art in Genitourinary Cancers

State of the Art in Genitourinary Cancers

By: Nicholas Mitsiades, MD, PhD

State of the Art in Genitourinary Cancers

State of the Art in Genitourinary Cancers

By: Nicholas Mitsiades, MD, PhD

Panel-Optimal Therapies in Genitourinary Cancers

Panel-Optimal Therapies in Genitourinary Cancers

By: Panel

Optimal Therapies in Genitourinary Cancers

Optimal Therapies in Genitourinary Cancers

By: Panel

Kidney & Bladder Cancer: Targeted, Immuno & Other Strategies

Kidney & Bladder Cancer: Targeted, Immuno & Other Strategies

By: Pedro Barata, MD, MSc

Renal Cell Carcinoma (RCC): Current Approach to First Line Therapy and Beyond

Renal Cell Carcinoma (RCC): Current Approach to First Line Therapy and Beyond

By: Petros Grivas, MD, PhD

Renal Cell Carcinoma (RCC): Current Approach to First Line Therapy and Beyond

Renal Cell Carcinoma (RCC): Current Approach to First Line Therapy and Beyond

By: Petros Grivas, MD, PhD

Targeted Therapies in Metastatic RCC: Monotherapy Versus Combination Therapy

Targeted Therapies in Metastatic RCC: Monotherapy Versus Combination Therapy

By: Primo N Lara - Jr. - MD

Renal Cell Cancer: Navigating a Maze of Choices

Renal Cell Cancer: Navigating a Maze of Choices

By: Primo N. Lara, Jr. (UCD)

Targeted Therapies in Metastatic RCC Monotherapy versus Combination Therapy

Targeted Therapies in Metastatic RCC Monotherapy versus Combination Therapy

By: Primo N. Lara, Jr., MD

Clinical Applications for Liquid Biopsy in
GU Cancers Update

Clinical Applications for Liquid Biopsy in GU Cancers Update

By: Rafee W. Talukder, MD

State of the Art in Genitourinary Cancers

State of the Art in Genitourinary Cancers

By: RALPH DE VERE WHITE, MD

State of the Art in Genitourinary Cancers

State of the Art in Genitourinary Cancers

By: Ralph deVere White, MD

Prostate Cancer: Role of PSMA PET and Accurately Defining “Neuroendocrine” Prostate

Prostate Cancer: Role of PSMA PET and Accurately Defining “Neuroendocrine” Prostate

By: Ravi A. Madan, MD

Prostate Cancer: Role of PSMA PET and Accurately Defining “Neuroendocrine” Prostate

Prostate Cancer: Role of PSMA PET and Accurately Defining “Neuroendocrine” Prostate

By: Ravi A. Madan, MD

Immunotherapy for GU Malignancies and Exciting Developments

Immunotherapy for GU Malignancies and Exciting Developments

By: Rohit Jain, MD, MPH

Immunotherapy for GU Malignancies and Exciting Developments

Immunotherapy for GU Malignancies and Exciting Developments

By: Rohit Jain, MD, MPH

Sequencing drugs in mCRPC

Sequencing drugs in mCRPC

By: Sandy Srinivas, MD

Castration Resistant Prostate Cancer: What is the optimal approach?

Castration Resistant Prostate Cancer: What is the optimal approach?

By: Sandy Srinivas, MD

Advanced Urothelial Cancer

Advanced Urothelial Cancer

By: Sarmad Sadeghi, MD, PhD

Systemic Therapy in Urothelial Carcinoma

Systemic Therapy in Urothelial Carcinoma

By: Sarmad Sadeghi, MD, PhD

«
1
…
26
27
28
29
30
…
103
»

Post navigation

← Previous View

© 2024 MEC Inc. All rights reserved | Digital Marketing by Katapult Marketing

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok